Waddell & REED Investment Management Co. is 10% Owner at MARRONE BIO INNOVATIONS INC (MBII). They have made 5 open-market trades across 1 company since 2014, most recently 2018-02-05.
CIK 0000903764
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $3.1M since 2014, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MBII | 2,031,283 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2018-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBII | SELL | 2017-02-01 | 2018-02-07 | $2.16 | $24K | +1.7% | +53.8% | +50.4% |
| MBII | BUY | 2014-05-16 | 2018-02-07 | $9.25 | $447K | +1.7% | +53.8% | +50.4% |
| MBII | BUY | 2014-05-15 | 2018-02-07 | $9.23 | $1.6M | +1.7% | +53.8% | +50.4% |
| MBII | BUY | 2014-05-14 | 2018-02-07 | $8.59 | $966K | +1.7% | +53.8% | +50.4% |
| MBII | BUY | 2014-05-14 | 2018-02-07 | $9.46 | $137K | +1.7% | +53.8% | +50.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.